e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Exhaled biomarkers in children and adults with airways disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain
Ulla Seppala (Solna, Sweden), Ulla Seppala, Lorenzo Sabatelli, Joaquín Sastre, Glenn Crater
Source:
International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Session:
Exhaled biomarkers in children and adults with airways disease
Session type:
Poster Discussion
Number:
2088
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ulla Seppala (Solna, Sweden), Ulla Seppala, Lorenzo Sabatelli, Joaquín Sastre, Glenn Crater. Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain. Eur Respir J 2015; 46: Suppl. 59, 2088
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Cost savings using fractional exhaled nitric oxide (FeNO) testing in asthma management by specialists
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Alveolar nitric oxide and its role in asthma control assessment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Associations between fractional exhaled nitric oxide (FeNO), asthma, respiratory symptoms and self-reported allergies in female university students in Kobe, Japan
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study
Source: Eur Respir J 2011; 37: 523-531
Year: 2011
Interaction between airway calibre and exhaled NO: Impact on asthma control assessment
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
The impact of fractional exhaled nitric oxide (FeNO) measurement on treatment decision making in the specialist care of established asthma
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
The effect of bronchodilation and spirometry on exhaled nitric oxide
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016
The levels of exhaled nitric oxide in controlled asthmatic patients with and without rhinitis
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Educational intervention decreases exhaled nitric oxide in farmers with occupational asthma
Source: Eur Respir J 2007; 30: 545-548
Year: 2007
Positive relationship between offline exhaled nitric oxide and lung clearance index in pre-school wheezers
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014
Exhaled nitric oxide variations during oral challenge with different NSAIDs in patients with aspirin-induced asthma
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
The relationship between exhaled nitric oxide and body mass index in controlled an uncontrolled Tunisian asthmatics
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Exhaled nitric oxide reference values in healthy Tunisian adults
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013
Indoor room nitric oxide and alveolar nitric oxide in the Southern California children’s health study
Source: International Congress 2015 – Highlights in paediatric epidemiology: air pollution, asthma and primary ciliary dyskinesia
Year: 2015
Effect of tobacco smoke exposure on exhaled nitric oxide levels in Tunisian asthmatics
Source: International Congress 2016 – Airway biomarkers
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept